Agamon
Agamon is an AI-powered healthcare platform that converts clinical text into structured data.
Agamon has raised €2.7M across 1 funding round from 1 investor, most recently a Seed round in Jun 2020. Based in New York, United States; founded 2018; active in AI. Data as of 28 Oct 2026.
Total raised
€2.7M
€2,676,182
Funding rounds
1
Investors
1
distinct backers
Active since
2020-06
latest 2020-06
Funding by year
EUR raised per yearAgamon — funding by year — interactive chart.
Data table
| Agamon — funding by year | |
|---|---|
| 2020 | €2.7M |
Signals
High confidenceRaise-next likelihood9
base rate 44% for Seed
- ▼ Dormant (no round in 3+ cohort gaps)
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-06-22 | Seed | €2.7M | MMC Ventures | View deal → |
Investors
1Related news
Similar companies
same sector or country- Mistral AI€6.5BFrance · AI
- Helsing€2.9BGermany · AI
- UiPath€1.7BRomania · AI
- ElevenLabs€1.2BUK · AI
- Ineffable Intelligence€936MUK · AI
- Advanced Machine Intelligence (AMI)€885MFrance · AI
Global coverage: FundingData